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28 ABSTRACT 
29 Aims: To characterize postprandial glucose flux after exercise in the fed versus 
30 overnight fasted-state and to investigate potential underlying mechanisms.  
31 Methods: In a randomized order, twelve men underwent breakfast-rest (BR; 3 h 
32 semi-recumbent), breakfast-exercise (BE; 2 h semi-recumbent before 60-min of 
33 cycling (50% peak power output) and overnight fasted-exercise (FE; as per BE 
34 omitting breakfast) trials. An oral glucose tolerance test (OGTT) was completed 
35 post-exercise (post-rest on BR). Dual stable isotope tracers ([U-13C] glucose 
36 ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined to 
37 assess postprandial plasma glucose kinetics and intramuscular signaling, 
38 respectively. Plasma intestinal fatty acid binding (l-FABP) concentrations were 
39 determined as a marker of intestinal damage. Results: Breakfast before 
40 exercise increased post-exercise plasma glucose disposal rates during the 
41 OGTT, from 44 g-120 min-1 in FE [35 to 53 g-120 min-1] (mean [normalized 95% 
42 Cl]) to 73 g-120 min-1 in BE [55 to 90 g-120 min-1; p = 0.01]. This higher plasma 
43 glucose disposal rate was, however, offset by increased plasma glucose  
44 appearance rates (principally OGTT-derived), resulting in a glycémie response 
45 that did not differ between BE and FE (p = 0.11). Plasma l-FABP concentrations 
46 during exercise were 264 pg-mL-1 [196 to 332 pg-mL-1] lower in BE versus FE 
47 (p = 0.01). Conclusion: Breakfast before exercise increases post-exercise 
48 postprandial plasma glucose disposal, which is offset (primarily) by increased 
49 appearance rates of orally-ingested glucose. Therefore, metabolic responses to  
50 fed-state exercise cannot be readily inferred from studies conducted in a fasted  
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53 INTRODUCTION 
54 Postprandial glycemia is a strong predictor of future mortality and morbidity.  
55 Even in people without diabetes, those with greater blood glucose excursions  
56 after feeding are at an increased risk of cardiovascular disease (47, 48). This  
57 glycémie response to food ingestion is dictated by blood glucose kinetics (i.e.  
58 the balance between the rates of glucose appearance into blood and glucose  
59 disposal from blood into peripheral tissues). Exercise potently increases 
60 glucose disposal from the blood into skeletal muscle (52), and regular exercise  
61 is therefore recommended as a lifestyle strategy to improve glycémie control. 
62  
63 Habitual responses to exercise and nutrition are however, the culmination of not 
64 only chronic adaptations, but also the acute effects of each exposure to these  
65 daily behaviors (5, 6, 22). For example, each bout of exercise potently 
66 stimulates post-exercise insulin sensitivity and muscle glucose uptake (52). 
67 However, despite increases in blood glucose disposal rates, endurance-type 
68 exercise does not always reduce postprandial glucose excursions in the post - 
69 exercise period (20, 54). The finding that postprandial blood glucose  
70 concentrations are not lowered post-exercise is because when exercise is 
71 performed (at least in the fasted state), the increase in postprandial blood 
72 glucose disposal after exercise can be offset - and even superseded - by 
73 increases in both endogenous and meal-derived blood glucose appearance 
74 rates (34, 54).  
75  
  
Page 6 
 
 
76 Whilst fasting prior to laboratory trials is common in order to control for baseline  
77 metabolic status, these conditions may preclude the application of findings to  
78 situations most representative of daily living. For example, most people living in 
79 developed countries spend the majority of a typical day in the postprandial state  
80 (13, 55). Therefore, most eating occasions and exercise sessions will take place 
81 in the context of this postprandial situation (23). It has previously been shown 
82 by others that plasma glucose fluxes during exercise (16), and by us that 
83 plasma glucose concentrations after exercise (24), are elevated by pre-exercise 
84 feeding. However, the effect of prior feeding on post-exercise plasma glucose 
85 flux has never been assessed. Therefore, there is a distinct lack of 
86 understanding regarding postprandial glucose kinetics under scenarios that are  
87 most representative of daily living, and it may not be valid to generalize existing  
88 observations of exercise in the fasted state. Moreover, an understanding of the 
89 underlying mechanisms responsible for any differences in postprandial glucose  
90 flux post-exercise, with prior feeding versus fasting, is still required. 
91  
92 This study therefore aimed to characterize postprandial plasma glucose kinetics 
93 after: 1) breakfast and rest; 2) breakfast and exercise and 3) overnight fasted- 
94 state exercise, while also exploring potential mechanisms (intramuscular  
95 signaling and markers of intestinal damage) to explain any differences in  
96 glucose flux between these conditions.  
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97 MATERIALS AND METHODS 
98 Ethical Approval 
99 All trials were undertaken at the University of Bath (Bath, UK) in accordance 
100 with the Declaration of Helsinki. The study was approved by the National Health  
101 Service South-West Research Ethics Committee (reference: 15/SW/0006) and 
102 registered at clinicaltrials.gov as NCT02258399. Written, informed consent was  
103 obtained from all participants prior to their participation. 
104  
105 Study Design 
106 This study was a randomized cross-over design (randomization performed by 
107 JTG with Research Randomizer version 3.0, http://www.randomizer.ora/). 
108 Preliminary testing was followed by three trials (separated by > 7 d), namely,  
109 breakfast-rest (BR), breakfast-exercise (BE) and overnight fasted-exercise (FE). 
110 A schematic for the study protocol is shown in Figure 1. For all trials 
111 participants arrived at the laboratory after a 12 to 14-h overnight fast. In BR, a 
112 porridge breakfast was consumed, followed by 3 h of rest, and then a 2-h oral 
113 glucose tolerance test (OGTT). In BE, the same breakfast was consumed,  
114 before 2 h rest and 60 min of cycling, prior to the OGTT. In FE, breakfast was 
115 omitted but the trial otherwise replicated BE. By necessity of design (food  
116 intake/exercise) the intervention was open label. Within-lab testing conditions 
117 were not different across the trials ([mean ± SD] ambient temperature [23.7 ±  
118 0.5 °C on BR, 23.7 ± 0.6 °C on BE, 23.6 ± 0.7 °C on FE) and barometric  
119 pressure [734 ± 5 mmHg on BR, 736 ± 6 mmHg on BE, 736 ± 5 mmHg on FE]; 
120 all p > 0.05).
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122 
Participants 123 
Twelve healthy and physically active men (self-reported as regular exercisers 124 
engaging in at least 30 min of exercise a minimum of 3 times per week) were 125 
recruited from Bath and North East Somerset, between May and November 126 
2015. Participant characteristics are shown in Table 1. Exclusion criteria 127 
included any history of metabolic disease, or condition that may have posed 128 
undue personal risk to the participant or introduced bias to the study.  129 
130 
Preliminary Testing 131 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted after 
breakfast followed by rest (BR), breakfast followed by exercise (BE), or extended 
overnight fasting followed by exercise (FE). Dual stable isotope tracers ([U-13C] 
glucose ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined
to assess postprandial plasma glucose kinetics and intramuscular signaling, 
respectively. 
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132 Participants were asked to refrain from strenuous physical activity for 24 h prior 
133 to preliminary testing, but were asked to otherwise maintain their normal  
134 physical activity behaviors. They abstained from alcoholic and caffeinated 
135 drinks for 24 h prior to this visit. Food intake ceased at 8 pm on the evening 
136 before testing and participants fasted overnight (minimum 12 h), consuming 
137 only water {ad libitum) during this period. In addition, they were asked to 
138 consume 568 ml_ of water at least 1 h prior to testing, and to void immediately 
139 prior to arriving at the laboratory. Upon arrival, the participant’s stature was  
140 measured (Frankfurt plane) to the nearest 0.1 cm using a stadiometer (Seca 
141 Ltd, Birmingham, UK). Body mass was recorded to the nearest 0.1 kg (only light  
142 clothing permitted) using electronic weighing scales (BC543 Monitor, Tanita, 
143 Tokyo, Japan). A whole-body dual energy x-ray absorptiometry scan was 
144 completed to quantify fat and fat-free mass (DEXA; Discovery, Hologic, 
145 Bedford, UK). 
146  
147 Participants then performed an incremental cycling exercise test at a self- 
148 selected cadence on an electronically-braked ergometer (Excalibur Sport, Lode 
149 Lode® Groningen, Netherlands). They were permitted to adjust the saddle and  
150 handlebar heights to their preferred position, which were replicated for cycl ing 
151 during the exercise trials. The initial exercise intensity was 50 W and this was  
152 increased by 50 W every four min, for four stages. Thereafter, the intensity was 
153 increased by 20 W every min until volitional exhaustion. Heart rate (Polar 
154 Electro Oy, Kempele, Finland) and continuous breath-by-breath measurements 
155 were recorded throughout (TrueOne2400, ParvoMedics, Sandy, USA). Volume  
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156 and gas analyzers were calibrated with a 3 L calibration syringe (Hans Rudolph,  
157 Kansas City, USA) and a calibration gas (balance nitrogen mix; 16.04% O2, 
158 5.06% CO2; BOC Industrial Gases, Linde AG, Munich, Germany), respectively.  
159 Peak power output (PPO) was calculated as the work rate of the last completed 
160 stage, plus the fraction of time spent in the final non-completed stage, multiplied 
161 by the work rate increment. Peak oxygen uptake (̇VO2реак) was calculated as 
162 the highest average VO2 over a rolling 30-s period. 
163  
164 Main Trials 
165 Participants refrained from strenuous physical activity, alcohol and caffeine for  
166 24 h before all trials. They recorded the composition of their evening meal on 
167 the day before the first main trial and replicated this meal for subsequent trials,  
168 in accordance with procedures for standardizing postprandial glucose tolerance 
169 testing (10). This pre-trial standardisation protocol has been previously shown 
170 to be effective at producing overnight-fasted muscle glycogen concentrations, 
171 liver glycogen concentrations and intramyocellular lipid that are standardised  
172 across multiple trial days, in a similar population (21). To help ensure physical 
173 activity standardization, participants completed a physical activity diary and  
174 wore a physical activity monitor (Actiheart™; Cambridge Neurotechnology,  
175 Papworth, UK) for 24 h before all trials (pre-trial 24-h physical activity energy 
176 expenditure [(mean ± standard deviation) 988 ± 500 kcal on BR, 1022 ± 521 
177 kcal on BE, 992 ±313 kcal on FE; all p > 0.05; n = 9]. 
178  
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179 Participants arrived at the laboratory at 0800 ± 1 h following a 12 to 14-h 
180 overnight fast and this arrival time was replicated for the subsequent trials. They 
181 were asked to void and all further urine samples were collected for the 
182 remainder of the trial to allow for urinary nitrogen excretion to be estimated from 
183 urine urea concentrations. Participants then placed their dominant hand into a 
184 heated-air box (Mass Spectrometry Facility; The University of Vermont & 
185 University of Vermont Medical Center, Burlington, USA) set to 55 °C. After 20 
186 min of rest, an intravenous catheter (BD Venflon Pro, BD, Helsingborg, 
187 Sweden) was fitted into a heated dorsal hand vein (retrograde) and a 10-mL 
188 baseline blood sample was drawn, before a 5-min expired gas sample was 
189 collected. On the first main trial for each participant (see Figure 1), a baseline 
190 muscle sample was taken from the vastus lateralis to allow for an assessment 
191 of the pathways involved in exercise and insulin signaling in muscle [5' AMP- 
192 activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), protein kinase 
193 В (herein refered to as Akt2), and Akt substrate of 160 kDa (AS160). 
194  
195 In BE and BR, a porridge breakfast was then consumed within 10 min (3 h pre- 
196 OGTT) and in FE participants were allowed water only. The breakfast was 72 g 
197 of instant refined oats (Oatso Simple Golden Syrup, Quaker Oats) and 360 ml_ 
198 of semi-skimmed milk (Tesco), providing 431 kcal of energy ([1803 kJ]; 65 g 
199 CHO, 11 g FAT, 19 g PRO). The breakfast was high-carbohydrate (57% of 
200 energy intake) and high glycemic-index [oatmeal, made from mix (Quaker Oats) 
201 has a glycemic index of 69 (17)], as is commonly consumed in developed 
202 countries. Due to the co-ingestion of milk, this breakfast would produce a high  
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203 insulinemic response (38, 46). Breakfast consumption (or omission on FE) was  
204 followed by 2 h of rest, where participants remained in a semi-recumbent 
205 position, completing resting activities (e.g. watching television), with expired gas  
206 samples collected every 60 min. After 1 h 40 min of rest, (1 h 20 min pre-OGTT) 
207 a catheter was inserted into an antecubital vein (the contralateral arm to the one 
208 used for blood sampling). A primed infusion of [6,6 -2H2]glucose was initiated 
209 and continued for the remaining within-lab component of the trial (Cambridge 
210 Isotope Laboratories, MA, USA; prime: 13.5 µmol.kg-1; infusion: 0.35 
211 µmol.kg-1.min-1). After 20 min (60 min pre-OGTT), and on BE and FE only, 
212 participants began 60 min of cycling at 50% PPO on an ergometer (Lode 
213 Corival, Lode B.V, Groningen, Netherlands). The cadence was self-selected 
214 (replicated for both exercise trials) and the power output was monitored via a  
215 computerized system. In BR, participants remained rested in the semi- 
216 recumbent position during this period. Expired gas samples were collected  
217 every 15 min and blood samples were collected at 40 and 50 min of exercise 
218 (20 and 10 min pre-OGTT). Immediately post-exercise (or post-rest in BR) a 
219 muscle sample was taken from the vastus lateralis. Then a 2-h OGTT was 
220 completed, with arterialized blood sampled at 10-min intervals and expired gas 
221 sampled every 60 min. The OGTT was 73 g of glucose (81 g of dextrose 
222 monohydrate when corrected for water content; Myprotein, Northwich, UK) and  
223 2 g of [U-13C]glucose (99%; Cambridge Isotope Laboratories, MA, USA), to 
224 allow the rate of appearance of the orally ingested glucose (RaOGTT) to be 
225 assessed. A final muscle sample was taken post-OGTT (OGTT 120 min). 
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227 Tracer approach, blood sampling and analysis 
228 A dual-tracer approach was employed, where the tracer infusion rate was 
229 doubled during exercise (on BE and FE) to account for an expected increase in 
230 endogenous glucose production (1) and reduced to 80% of baseline at OGTT 
231 20 min (all trials) to account for an expected suppression of endogenous  
232 glucose production after oral glucose ingestion (9). This approach reduces 
233 changes in the tracer-to-tracee ratio, thereby permitting more accurate 
234 estimations of glucose kinetics(4). Arterialized blood was sampled from a  
235 heated dorsal hand vein at baseline, at 60-min intervals during the initial 2-h 
236 rest period, at 40 and 50 min of the exercise period (or post-rest in BR) and at 
237 10-min intervals during the OGTT. Whole blood was dispensed into 
238 ethylenediaminetetraacetic acid-coated tubes (BD, Oxford, UK) which were first  
239 centrifuged (4 °C and 3500 g) for 10-min (Heraeus Biofuge Primo R, Kendro 
240 Laboratory Products Pic., UK) to obtain plasma. The plasma was then 
241 dispensed into 0.5 mL aliquots and immediately frozen at -20 °C, before longer- 
242 term storage at -80 °C. 
243  
244 Plasma glucose (intra-assay coefficient of variation [CV], 3.2%; inter-assay CV 
245 3.8%), lactate (intra-assay CV, 1.0%; inter-assay CV 4.8%), and triglyceride 
246 (intra-assay CV, 1.4%; inter-assay CV 4.0%) concentrations were measured 
247 using an automated analyzer (Daytona; Randox Lab, Crumlin, UK) as per the  
248 manufacturer’s instructions. Plasma insulin concentrations were measured  
249 using a commercially available ELISA kit (Mercodia AB, Uppsala, Sweden; 
250 intra-assay CV, 5.7%; inter-assay CV 9.9%). Plasma intestinal fatty acid binding  
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251 protein (l-FABP) concentrations were measured as a marker of intestinal cell 
252 damage using a commercially available ELISA kit (Hycult Biotech; intra -assay 
253 CV, 6.0%). Plasma NEFA concentrations were determined using an enzymatic  
254 colorimetric assay (WAKO Diagnostics; intra-assay CV, 8.9%; inter-assay CV 
255 10.4%). For all of these analyses, all plasma samples were analyzed in batch 
256 after all sample collection was completed, and for a given participant all  
257 samples (from the three trials) were run on the same plate. 
258  
259 Plasma [U-13C]glucose and [2H2]glucose enrichments were determined by gas 
260 chromatography-mass spectrometry (GC-MS: GC, Agilent 6890N; MS, Agilent 
261 5973N; Agilent Technologies, Stockport, UK). Plasma glucose was extracted 
262 using methanol-chloroform and hydrochloric acid, dried under nitrogen gas, and 
263 then derivatised using the heptofluorobuyric acid method as previously  
264 described(30). The glucose derivative was acquired by selected ion monitoring  
265 at mass-to-charge ratios (m/z) 519, 521 and 525 for [12C], [6,6-2H2]- and [U-
13C]- 
266 glucose, respectively. Glucose enrichments of [13C] and [2H2] in plasma were 
267 determined using standard curves for [13C] and [2H2] glucose, and enrichments 
268 were expressed relative to those at 519 (M+0). The baseline sample was used  
269 for every trial to account for background isotopie plasma enrichments. To 
270 reduce any impact of analytical variability on calculations of glucose kinetics,  
271 glucose and enrichment data were curve fitted as previously described (63).  
272  
273 Muscle sampling and analysis  
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274 Muscle samples were collected from the vastus lateralis under local anesthesia 
275 (~5 ml_ of 1% lidocaine, Hameln Pharmaceuticals Ltd., Brockworth, UK). 
276 Samples were taken from a 3-5-mm incision at the anterior aspect of the thigh 
277 with a 5-mm Bergstrom biopsy needle technique adapted for suction(57). 
278 Samples were immediately extracted from the needle and frozen in liquid 
279 nitrogen, before longer-term storage at -80 °C. The order of dominant or non- 
280 dominant leg was counterbalanced across trials for the OGTT 0 min and the 
281 120 min samples. Samples were taken from separate skin incision sites, with 
282 these > 2 cm proximal to any previous incision on the same leg (59). For the  
283 OGTT 0 min sample (post exercise [or post-rest in BR]) the incision was made 
284 prior to cycling (BE and FE) and closed with Steristrips, to allow for an 
285 immediate sample to be taken post-exercise. 
286  
287 Frozen wet tissue (20-30 mg) was freeze-dried, powdered, and dissected free 
288 of visible blood and connective tissue and added to ice cold lysis buffer [50 mM 
289 Tris (pH 7.4), 150 mM NaCI, 0.5% Sodium deoxycholate; 0.1% SDS and 0.1% 
290 NP-40] with a protease (Thermo Scientific) and phosphatase inhibitor cocktail  
291 (Millipore). Samples were homogenized with a dounce homogenizer (~ 40 
292 passes), incubated for 60 min at 4 °C with rotation, and centrifuged for 10 min 
293 (4 °C and 20,000 g). The protein content of the resultant supernatant was 
294 measured via a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific).  
295 For Western blots, an equal amount of protein (40 µg) was loaded per lane for 
296 each sample and separated using sodium dodecyl sulfate polyacrylamide gel  
297 electrophoresis (SDS-PAGE) on Tris-glycine SDS-polyacrylamide gels (7% for  
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298 p-AMPKThr172, total AMPK, p-ACCSer79 and total ACC, 10% for p-AktSer473 and 
299 total Akt2 and 8% for p-AktThr308, p-AS160Thr642 and total AS160). Gels were 
300 electro-blotted using a semi-dry transfer onto a nitrocellulose membrane. 
301 Membranes were washed in Tris-buffered saline (0.09% NaCI, 100 mM Tris- 
302 HCI pH 7.4) with 0.1% Tween 20 (TBS-T) and incubated for 30-min in a 
303 blocking solution (5% non-fat dry milk in TBS-T; Marvel, Premier International 
304 Foods Ltd, UK). The membranes were incubated overnight at 4 °C with primary 
305 antibodies against p-AMPKThr172, p-ACCSer79, p-AktSer473, p-AktThr308 and p- 
306 AS160Thr642 (Cell Signaling Technologies, USA). In the morning, membranes 
307 were washed in TBS-T and incubated with a 1:4000 dilution of anti-species IgG 
308 horseradish peroxidase-conjugated secondary antibodies made up in the 
309 aforementioned blocking solution. After further washes, membranes were 
310 incubated in an enhanced chemiluminescence (ECL) reagent and visualized 
311 using a chemiluminescent imager (EpiChemi II Darkroom, UVP, Upland, USA).  
312 Nitrocellulose membranes were then incubated for 30-min at 50 °C in a 
313 stripping solution [62.5 mM Tris pH 6.7, 2%SDS, 100 mM 2-mercaptoethanol], 
314 before re-blotting for total AMPK, total ACC, total Akt2 (Cell Signaling 
315 Technologies, USA) and total AS160 (Merck-Milliopore, UK). For these 
316 analyses, all samples from each participant (all three trials) were run on the 
317 same gel. Band densities were quantified using VisionWorksLS Image  
318 Acquisition and Analysis Software for Windows (UVP, Upland, USA). For all of  
319 the signalling molecules reported in this experiment a ratio of phosphorylated to  
320 total protein was calculated and the results were expressed relative to the 
321 baseline sample.  
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322  
323 Substrate utilization 
324 Expired gas samples were collected at baseline, during the initial 2-h rest period 
325 and the OGTT at 60-min intervals (for 5 min), and at 15-min intervals (for 1 min) 
326 during the exercise period (or rest in BR). For all samples, participants were  
327 provided with the mouthpiece 1 min before gas collections for a stabilization 
328 period. Samples were collected in 200 L Douglas bags (Hans Rudolph, Kansas  
329 City, USA) through falconia tubing (Baxter, Woodhouse and Taylor Ltd,  
330 Macclesfield, UK). Concurrent measures of inspired air were made to correct for  
331 changes in ambient O2 and CO2 concentrations(7). Expired O2 and CO2 
332 concentrations were measured in a known volume of each sample, using 
333 paramagnetic and infrared transducers respectively (Mini HF 5200, Servomex  
334 Group Ltd., Crowborough, East Sussex, UK). The sensor was calibrated using  
335 concentrations of low (99.998% Nitrogen, 0% O2 and CO2) and high (balance 
336 nitrogen mix, 16.04% O2, 5.06% CO2) calibration gases (both BOC Industrial 
337 Gases, Linde AG, Munich, Germany). Urinary nitrogen excretion was estimated 
338 from urine urea concentrations, which were measured on an automated 
339 analyzer (Daytona; Randox Lab, Crumlin, UK), to allow for protein oxidation to 
340 be accounted for in calculations of substrate utilization rates.  
341  
342 Calculations and statistical analysis 
343 A sample size estimation was completed a priori with the total rate of plasma 
344 glucose appearance as the primary outcome measure. Rose et al. (54) reported 
345 a difference in the total plasma glucose appearance of (mean ± SD) 1600 ±  
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1300 µmol·kg-1 during an OGTT after rest versus after fasted exercise. Using 346 
this effect size, and an alpha level of 0.05, we calculated that 12 participants 347 
were required for an 80% probability of statistically detecting an effect in the 348 
RaTOTAL using a crossover design with three trials and a two-tailed, one-way 349 
ANOVA.   350 
351 
The total and incremental area underneath the concentration-time curve (AUC 352 
or iAUC, respectively) for each plasma metabolites or hormones was calculated 353 
using the trapezoid rule. The AUC or iAUC for each plasma metabolite or 354 
hormone was then divided by either the duration of the total within-lab period 355 
(300-min) or the OGTT observation period (120-min), as appropriate, to provide 356 
a time-averaged value (mmol·L-1), which are used as summary measures. 357 
Plasma glucose and insulin concentrations during the OGTT were used to 358 
estimate insulin sensitivity (ISI) according to the equation of Matsuda (41): [FPG 359 
and FPI are fasting plasma glucose and insulin concentrations, and MPG and 360 
MPI are mean plasma glucose and insulin concentrations in the OGTT (41)]: 361 
362 
ISIMATSUDA(au) =
10,000
√FPG(mgdL-1)•FPI(mIUmL-1)•MPG(mgdL-1)• MPI(mIUmL-1)
363 
Plasma glucose kinetics were determined using Radziuk’s two-compartment 364 
non-steady state model (50, 51) and SAMM II software (SAAM II v2.3, The 365 
Epilson Group, Charlottesville, VA, USA). This model reduces errors in 366 
estimations of glucose kinetics that are apparent when using Steele’s (56) one 367 
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compartment model (53). The total rate of plasma glucose appearance 368 
(RaTOTAL) and glucose disappearance (Rd) were calculated as follows:  369 
370 
Equation 1: 371 
RaTOTAL(t) =
F
E1(t)
-
V1∙G(t)
E1(t)
∙Ė1(t)+k12 (
q
2
iv(t)
E1(t)
-Q2(t))
Equation 2: 372 
Rd (t) =RaTOTAL-V1∙Ġ(t) -k21∙V1∙G(t) +k12∙Q2(t)
373 
Where F is the [6,6-2H2] infusion, V1 is the glucose volume of distribution [4% of374 
body mass (kg)], E1(t) the [
2H2] plasma glucose enrichment (mole percent375 
excess) at time t, Ė1 (t) the change in E over time [derivate of E], G(t) the 376 
plasma glucose concentrations at time t, Ġ(t) the change in G over time 377 
[derivate of G],  k12 and k21 are fixed rate constants between the peripheral and 378 
the accessible compartments (0.05 min-1 and 0.07 min-1 respectively) and q2
iv
379 
and Q2 are the amounts of the tracer [
2H2] and tracee in the peripheral380 
compartment respectively, evaluated by integrating the two-compartment 381 
model.  382 
383 
The [U-13C] enrichment of the orally ingested glucose and the RaTOTAL (from384 
Equation 1) were used to calculate the plasma rate of appearance of glucose 385 
from the OGTT (RaOGTT). In these equations, r1 is the ratio of the infusion [
2H2]386 
and oral [U-13C] glucose tracer concentrations in plasma, ṙ (t) is the change in r 387 
over time [derivate of r], g is the [U-13C] glucose tracer in plasma, qo
iv is the388 
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amount of the [U-13C] tracer in the peripheral compartment (by integrating the 389 
two-compartment model), and EOGTT is the [U-
13C] enrichment of the OGTT.390 
391 
Equation 3: 392 
raO(t) =RaTOTAL(t)
F
r1(t)
-
V1∙g(t)
r1(t)
∙ṙ1(t)+k12[
q
2
iv(t)
r1(t)
-q
2
0(t)] 
Equation 4: 393 
RaOGTT(t) =ra
O(t)[
1
EOGTT
]
The metabolic clearance rate was calculated as the Rd divided by the plasma 394 
glucose concentrations for a given time point (G1) 395 
396 
Equation5: 397 
Metabolic Clearance Rate = Rd(t) /G1 
Rates of whole-body fat and carbohydrate utilization were calculated using the 398 
expired gas samples and stoichiometric equations (31).  Adjustments were 399 
made to account for the contribution made by the oxidation of protein 400 
(estimated via urinary urea nitrogen). Plasma glucose utilization was assumed 401 
to be equivalent to the plasma glucose rate of disappearance (Rd) as has been 402 
confirmed previously(32). Muscle glycogen utilization during exercise (BE and 403 
FE only) was calculated as total carbohydrate utilization during exercise minus 404 
plasma glucose utilization during exercise. Due to these methods, this estimate 405 
of muscle glycogen utilization will include the utilization of other non-glucose 406 
carbohydrates (e.g. lactate). Both the production and utilization of ketone 407 
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408 bodies can influence the respiratory exchange ratio and therefore theoretically 
409 complicate the estimates of carbohydrate oxidation during exercise. However,  
410 during short-duration, moderate intensity exercise this effect is negligible (31).  
411 Within-lab, energy expenditure was determined assuming that lipids, glucose 
412 and glycogen give 40.81, 15.64 and 17.36 kJ g -1 respectively (31).  
413  
414 One-way, repeated measures ANOVA were used to assess differences 
415 between trials at baseline and for summary measures (e.g. AUCs). If multiple  
416 comparisons were necessary, two-way repeated measures ANOVAs (time x 
417 trial) was used to identify differences between trials. Degrees of freedom for F 
418 values were Greenhouse-Geisser corrected for epsilon < 0.75, with Huynh-Feldt 
419 corrections used for less severe asphericity. If time x trial interaction effects 
420 were identified, multiple paired r-tests were used to locate variance, with Holm- 
421 Bonferroni step-wise adjustments to control for inflated type I errors. Pearson r 
422 and Spearman R were used to explore correlations between variables display 
423 normal and non-normal distribution, respectively. Unless otherwise stated, data 
424 in text, figures and tables are means ± 95% confidence intervals, which were  
425 normalized by removing between-subject variance (presented as 95% nCI)(39). 
426 All statistical analyses were completed using IBM SPSS statistics version 22 for  
427 windows (IBM, New York, USA), with the exception of the Holm-Bonferroni 
428 step-wise adjustments and the calculation of normalized confidence intervals  
429 which were completed using Microsoft Excel [2013]. Graph Pad Prism 7 
430 software (La Jolla, CA, USA) was used for preparation of the manuscript  
431 figures. A complete set of muscle samples was only obtained from nine   
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432 participants. Due to cannulation difficulties, for one participant’s BR trial the last 
433 blood sample obtained was at OGTT 70 min and for a different participant’s BE  
434 trial the last sample was at OGTT 60 min. For these trials (2 of 36) the group 
435 average was used for the missing data. Sensitivity analysis was completed for 
436 all measures involving blood samples and including/excluding these two 
437 participants did not influence any of the primary outcome measures. For clarity,  
438 the n is presented in all figure and table legends. 
439  
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440 RESULTS 
441 Plasma glucose kinetics 
442 The plasma glucose disappearance rate (Rd) displayed a time x trial interaction 
443 (F =3.123, p = 0.05), whereby plasma glucose Rd was higher during exercise  
444 versus rest (Figure 2A). Compared to extended overnight fasting, breakfast  
445 ingestion prior to exercise further increased the plasma glucose Rd during and 
446 after exercise (i.e. during the OGTT; Figure 2A). A main effect of trial was 
447 detected for the plasma glucose Rd during the OGTT (F = 7.079, p = 0.01), 
448 whereby the Rd was 45 g-120 min-1 in BR [95% nCI: 36 to 62 g·120 min-1] 
449 versus 73 g·120 min-1 in BE ([95% nCI: 55 to 90 g·120 min-1;p = 0.09 versus 
450 BR) and 44 g·120 min-1 in FE [95% nCI: 35 to 53 g·120 min-1]; p = 0.01 versus 
451 BE). Metabolic clearance rates showed a main effect of trial, with the highest  
452 rates also apparent in BE (Figure 2B; F = 7.849, p < 0.01 versus BR and FE). 
453  
454 A main effect of trial was detected for RaT0TAL during the OGTT ([g·120 min-1]; F 
455 = 3.915, p = 0.05) which was highest in BE (Figure 2C). However, after post- 
456 hoc adjustment the difference between trials was less apparent (p = 0.19 for BE 
457 versus BR and p = 0.09 for BE versus FE). A similar pattern was observed for 
458 the rate of appearance of glucose from the OGTT in plasma (RaOGTT) and a trial 
459 x time interaction was detected (Figure 2D; F = 3.134, p = 0.04). A main effect 
460 of trial was detected for the total RaOGTT (F = 5.915, p = 0.02), which was 49 
461 g·120 min-1 in BE [95% nCI: 44 to 53 g·120 min-1] (65% of the OGTT [59 to 
462 71%]) versus 42 g·120 min-1 in BR [95% nCI: 36 to 46 g·120 min-1] (56% of the 
463 OGTT [50 to 62%]; p = 0.11 versus BE) and 41 g·120 min-1 in FE [95% nCI: 35  
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464 to 47 g] (55% of the OGTT [49 to 61%] p = 0.06 versus BE). The plasma 
465 enrichment of [2H2] - and [
13C]- glucose are shown in Figures 2E and 2F, 
466 respectively. 
467  
468 Plasma glucose concentrations 
469 No difference between trials was detected for plasma glucose concentrations at  
470 baseline (Figure ЗА; p > 0.05). Thereafter, a trial x time interaction was 
471 apparent (F = 2.957, p = 0.01). During the exercise period (rest in BR), plasma  
472 glucose concentrations were higher in BR versus BE at 40 min, and in BR 
473 versus FE at 50 min (both p < 0.05). At OGTT 0 min, glucose concentrations 
474 were higher in BR versus BE, and during the OGTT they were initially higher in 
475 BR versus BE and in BR versus FE (all p < 0.05), but no further differences 
476 were then detected (Figure ЗА). Peak plasma glucose concentrations were 
477 higher in BR versus BE (p = 0.03), but not different in BE versus FE (Table 2; p 
478 > 0.05). A main effect of trial was detected for the within-lab (300-min) glucose 
479 AUC which was higher in BR versus BE (Table 2; p = 0.05). However, no main 
480 effect of trial was detected for the OGTT (120-min) ¡AUC (Figure 4A; F = 2.524, 
481 p = 0.11). 
482
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Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  (B), the 
total rate of plasma glucose appearance (RaTOTAL) (C), the rate of appearance of glucose 
in plasma from the oral glucose tolerance test (RaOGTT) (D), and the plasma enrichments 
of [2H2]-glucose (E) and [
13C]-glucose (F) before and during an oral glucose tolerance test
that was conducted after breakfast followed by rest (BREAKFAST-REST), breakfast 
followed by exercise (BREAKFAST-EX), or extended overnight fasting followed by 
exercise (FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 
healthy men. a = difference between breakfast rest versus breakfast exercise; b = 
breakfast rest versus fasted exercise and c = breakfast exercise versus fasted exercise 
with p < 0.05. 
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485 
Figure 3. Plasma glucose (A), plasma insulin (B), plasma non-esterified fatty acids 
(NEFA; C), plasma β-hydroxybuturate (D) plasma triglyceride (E), and plasma 
intestinal fatty acid binding protein (IFAB-P; F) concentrations before and during an 
oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), or 
extended overnight fasting followed by exercise (FASTED-EX). Data are means ± 
normalized 95% confidence intervals. n = 12 healthy men. a = difference between 
breakfast rest versus breakfast exercise; b = breakfast rest versus fasted exercise 
and c = breakfast exercise versus fasted exercise with p < 0.05. 
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486 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma 
insulin (B) incremental area under the curves (iAUC) and the Matsuda 
insulin sensitivity index (C; ISIMATSUDA) for an oral glucose tolerance test 
conducted after breakfast followed by rest (BREAKFAST-REST), breakfast 
followed by exercise (BREAKFAST-EX), or extended overnight fasting 
followed by exercise (FASTED-EX). Data are means ± normalized 95% 
confidence intervals, with individual data shown as grey lines. n = 12 healthy 
men. 
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487 Plasma insulin concentrations 
488 At baseline, there was no difference between trials for plasma insulin  
489 concentrations (Figure 3B; p > 0.05). Main effects of time (F = 4.351, p < 0.01) 
490 and trial (F = 7.986, p < 0.01) were detected, but there was no trial x time 
491 interaction effect (F = 2.395, p = 0.07). Peak (and time to peak) plasma insulin 
492 concentrations are shown in Table 2. A main effect of trial was detected for the 
493 within-lab (300-min) insulin AUC which was higher in BR versus BE (p < 0.01), 
494 but not different in BE versus FE (Table 2; p = 0.10). A main effect of trial was 
495 apparent for the insulin OGTT iAUC [Figure 4B; (120-min) F = 5.132, p = 0.02] 
496 which was lower in BE versus BR [by 27.34 pmol·L-1 (95% nCI: 12.10 to 45.80 
497 pmol·L-1); p = 0.02] and lower in BE versus FE [by 28.67 pmol·L-1 (95% nCI: 
498 10.21 to 47.12 pmol·L-1); p = 0.04]. There was a main effect of trial for the 
499 ISIMATSUDA insulin sensitivity index (Figure 4C; F = 22.790, p < 0.01), which was 
500 higher in BE versus BR [by 8.45 au, (95% nCI: 6.42 to 10.47 au); p < 0.01] and 
501 in BE versus FE [by 6.49 au (95% nCI: 2.93 to 8.51 au); p < 0.01]. 
502  
503 Plasma non-esterified fatty acid (NEFA) concentrations 
504 A main effect of trial (F = 4.314, p = 0.04) was detected for plasma NEFA at 
505 baseline, with concentrations of 0.30 mmol·L-1 in BR (95% nCI: 0.25 to 0.35 
506 mmol·L-1), 0.45 mmol·L-1 in BE (95% nCI: 0.36 to 0.53 mmol·L-1; p = 0.03 BE 
507 versus BR) and 0.36 mmol·L-1 in FE (95% nCI: 0.31 to 0.44 mmol·L-1; p = 0.12 
508 FE versus BR and BE). Thereafter, a time x trial interaction effect was apparent 
509 (Figure 3C; F = 11.438, p < 0.01), where plasma NEFA concentrations were 
510 lowered by breakfast consumption in BR and BE, and remained lower during  
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511 the exercise in BE versus FE, before increasing during the initial OGTT period 
512 in BE and FE versus BR. A main effect of trial was detected for the total within- 
513 lab plasma NEFA (300-min) AUC and the NEFA OGTT (120-min) AUC which 
514 in both instances was lower in BR versus BE and FE (Table 2; all p < 0.01). 
515  
516 Other plasma metabolites 
517 No differences were detected between trials at baseline for plasma ß- 
518 hydroxybuturate concentrations (Figure 3D; p > 0.05). Thereafter, a time x trial 
519 interaction effect was apparent (F = 6.310, p < 0.01) where concentrations were 
520 lowered by breakfast in BR and BE. Plasma ß-hydroxybuturate concentrations 
521 remained lower during exercise in BE versus FE, but increased during the 
522 OGTT with BE and FE versus BR. However, with post-hoc adjustment, the 
523 differences between trials for plasma ß-hydroxybuturate concentrations became 
524 less clear (all p > 0.05). The within-lab (300-min) ß-hydroxybuturate AUC was 
525 lower with BR versus BE (p = 0.03), but did not differ in BE and FE (Table 2; p 
526 = 0.35). No baseline differences were detected for triglyceride concentrations  
527 (Figure 3E, p > 0.05) but a time x trial interaction effect was apparent (F = 
528 3.994, p < 0.01). There was an effect of trial for the within-lab (300-min) and 
529 OGTT (120-min) triglyceride AUC, which tended to be lower in FE versus BE, 
530 but with post-hoc adjustment this difference between trials was less clear 
531 (Table 2; p > 0.05). Plasma lactate concentrations at baseline were not different 
532 across trials (p > 0.05) but were lower in BR versus BE and FE in the exercise 
533 period (rest in BR) and at OGTT 0 min, but were then higher in BR versus BE 
534 during the OGTT (time x trial; F = 20.305, p < 0.01). No effect of trial was  
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535 detected for the total within-lab (300-min) lactate AUC, but a main effect of trial 
536 was detected for the lactate OGTT (120-min) AUC, which higher in BR versus 
537 BE (Table 2; p< 0.01). 
538  
539 Plasma intestinal fatty acid binding protein (l-FABP) concentrations 
540 There was no difference between trials at baseline for plasma l-FABP 
541 concentrations (Figure 3F; p > 0.05), but these were lower after breakfast (time 
542 x trial interaction effect; F = 6.844, p < 0.01) in BR and BE versus FE (both p < 
543 0.05). During and post-exercise (or rest in BR), l-FABP concentrations were 
544 lower in BR and BE versus FE and remained lower in BR versus FE until OGTT 
545 20 min (all p < 0.05). The within-lab (300-min) l-FABP AUC was lower in BR 
546 and BE versus FE (Table 2; p = 0.01 and p = 0.05 respectively). 
547  
548 Activation of exercise and insulin signaling pathways in skeletal muscle 
549 Time x trial interaction effects were apparent for AMPKThr172 (ratio p-AMPK to 
550 total-AMPK) and ACCSer79 (ratio pACC to total ACC) phosphorylation, if  
551 normalized to the baseline muscle sample (Figure 5A; F = 5.154, p = 0.04 and 
552 Figure 5B, F = 5.881, p = 0.02, respectively). Compared to the breakfast-rest 
553 trial (BR), skeletal muscle AMPKThr172 phosphorylation was higher post-exercise 
554 (or post-rest in BR) in the breakfast and exercise (BE) trial [by 1.9 fold (95% 
555 nCI: 0.9 to 2.8 fold); p = 0.04] and was also higher in BE versus the fasted- 
556 exercise (FE) trial [by 1.0 fold (95% nCI: 0.2 to 2.0 fold); p = 0.01]. A similar 
557 pattern was apparent for ACC phosphorylation, which was higher post -exercise 
558 (or post-rest in BR) in BE versus BR [by 6.7 fold (95% nCI: 5.4 to 8.0 fold); p =
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559 0.03] but did not differ between BE and FE (p = 0.09). By OGTT 120 min, 
560 ACCSer79and AMPKThr172 phosphorylation had returned to baseline levels in all 
561 three trials (all p > 0.05). No time x trial interaction ( F  =  2.110, p = 0.16) nor a 
562 main effect of trial (F  =  0.098, p = 0.83) was detected for AktSer473 (ratio p- 
563 AktSer473 to total-Akt2) phosphorylation (Figure 6A). A main effect of time {F  =  
564 9.907, p = 0.01) was observed, where AktSer473 phosphorylation was elevated at 
565 OGTT 120 min in all trials. Similarly no time x trial interaction {F  =  1.533, p = 
566 0.25) nor a main effect of trial ( F  =  0.484, p = 0.56) was detected for AktThr308 
567 (ratio p-AktThr308 to total-Akt2) phosphorylation (Figure 6B). A main effect of 
568 time { F  =  10.598, p = 0.01) was also detected for this phosphorylation site, 
569 whereby AktThr308 phosphorylation was elevated at OGTT 120 min in all trials. 
570 For AS160Thr642 phosphorylation (ratio p-AS160Thr642 to total-AS160), a time x 
571 trial interaction was detected (Figure 6C; F =  4.430, p = 0.03), whereby the 
572 AS160Thr642 phosphorylation was not different between BR and BE at any time, 
573 was higher pre-OGTT in BE compared to FE (p = 0.04), but was not different 
574 between BE and FE at 120-min post-OGTT (p = 0.69).
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Figure 5. The phosphorylation of 5' AMP-activated protein kinase (A; phospho AMPKThr172, 
ratio p-AMPK to total-AMPK) and the phosphorylation of acetyl-CoA carboxylase (B; 
phospho ACCSer79, ratio p-ACC to total-ACC) before (PRE-OGTT) and after (POST-OGTT) 
an oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST [BR]), breakfast followed by exercise (BREAKFAST-EX [BE]), or 
extended overnight fasting followed by exercise (FASTED-EX [FE]). All samples were 
taken from the vastus lateralis. Samples were normalized to the baseline muscle sample 
for each participant (collected in the resting fasted state on the first main trial for each 
participant). Data are means ± normalized 95% confidence intervals. n = 9 healthy men. 
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Figure 6. The phosphorylation of Akt2 (A; phospho AktSer473, ratio p-Akt Ser473 to total-Akt2 
and B; phosphor AktThr308, ratio p-AktThr308 to total-Akt2) and the phosphorylation of AS160 
(C; AS160Thr642, ratio p-AS160Thr642 to total-AS160) before (PRE-OGTT) and after (POST-
OGTT) an oral glucose tolerance test that was conducted after breakfast followed by rest 
(BREAKFAST-REST [BR]), breakfast followed by exercise (BREAKFAST-EX [BE]), or 
extended overnight fasting followed by exercise (FASTED-EX [FE]). All samples were 
taken from the vastus lateralis. Samples were normalized to the baseline muscle sample 
for each participant (collected in the resting fasted state on the first main trial for each 
participant). Data are means ± normalized 95% confidence intervals. n = 9 healthy men. 
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585  
586 Substrate utilization 
587 Across the duration of the trial carbohydrate utilization was higher in BE versus 
588 BR (Figure 7; by 514 kcal, [95% nCI: 452 to 576 kcal] and higher in BE versus 
589 FE (by 124 kcal, [95% nCI: 18 to 230 kcal], both p < 0.01). This difference in 
590 carbohydrate utilization between BE and FE was derived from a higher 
591 utilization of plasma glucose and other carbohydrate sources (i.e. primarily 
592 muscle glycogen, but also plasma lactate) in BE (p = 0.02 and p = 0.04 
593 respectively). Within-lab fat utilization did not differ between BR and BE (p = 
594 0.25), but was higher in FE versus BE (by 138 kcal, [95% nCI: -6 to 224 kcal], p 
595 = 0.03). Muscle glycogen utilization during exercise (g kg body mass'1) was 
596 positively correlated (R = 0.64, p < 0.01) with skeletal muscle ACCSer79 
597 phosphorylation (ratio p-ACC to total-ACC) after exercise conducted following 
598 breakfast consumption (BE) or extended overnight fasting (FE).  
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Figure 7. Substrate utilization after breakfast followed by rest (BREAKFAST-
REST), breakfast followed by exercise (BREAKFAST-EX), or extended 
overnight fasting followed by exercise (FASTED-EX). Within-lab substrate 
utilization was calculated assuming that the plasma glucose disappearance 
rate was equivalent to plasma glucose utilization. Glycogen utilization during 
exercise (on breakfast exercise and fasted exercise only) was calculated as 
total carbohydrate utilization (from indirect calorimetry) minus plasma 
glucose utilization during exercise. This estimate of muscle glycogen 
utilization will therefore include the utilization of other non-glucose (e.g. 
lactate) carbohydrates. GLU = glucose; M-GLY = muscle glycogen; PRO = 
protein. Data are presented as means ± normalized 95% confidence 
intervals. n = 12 healthy men.  
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602 DISCUSSION 
603 This is the first study to assess the effect of pre-exercise feeding on 
604 postprandial plasma glucose kinetics after exercise. Our data demonstrate that 
605 pre-exercise feeding increases plasma glucose disposal during meals 
606 consumed after exercise, despite lower insulinemia in this condition. 
607 Characterizing glucose flux at meals is important because this determines 
608 postprandial glycemia; a predictor of cardiovascular disease risk (47, 48). 
609 Previous work has only studied postprandial glucose flux after fasted-state 
610 exercise. As most people consume food and perform exercise while still in a 
611 postprandial period from a prior meal (13, 23, 55) our results describe the 
612 physiological responses to feeding that are more readily applicable to scenarios 
613 that are representative of normal daily living. Moreover, our novel data 
614 demonstrate that metabolic responses to exercise conducted in an overnight 
615 fasted state and to meals that are consumed post-exercise cannot be easily 
616 extrapolated to conditions where breakfast has been consumed. 
617  
618 The disposal of plasma glucose (the disappearance rate) into skeletal muscle is 
619 elevated after exercise, via insulin-dependent and -independent pathways (25). 
620 We observed a higher postprandial plasma glucose disposal rate with breakfast 
621 versus fasting before exercise. The higher postprandial plasma glucose rate of 
622 disposal with pre-exercise breakfast ingestion was apparent despite lower 
623 insulinemia in the breakfast-exercise trial. At rest, breakfast consumption 
624 improves glucose tolerance and insulin sensitivity at subsequent meals [known 
625 as the “second-meal effect” (5, 20, 26)]. Mechanisms likely relate to delayed  
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626 gastric emptying (19), a potentiation of early phase insulinemia at the second 
627 meal (37) and enhanced glucose uptake into muscle due to increased GLUT4 
628 trafficking (18). Our findings show that breakfast ingestion (versus fasting) prior 
629 to exercise enhances subsequent glucose disposal at post-exercise meals in 
630 the presence of lower insulinemia, suggesting that the second-meal effect is 
631 maintained even if exercise is performed between meals. Whilst the effects of 
632 pre-exercise feeding on the metabolic responses during subsequent exercise is 
633 well characterised (15, 43), our data therefore provide new insights regarding 
634 postprandial glucose metabolism after exercise in the fed versus fasted state. 
635  
636 Molecular insulin-signaling pathways are instrumental mediators of glucose 
637 disposal in response to exercise and/or nutrition (11). We therefore determined 
638 the activation status of key proteins involved in glucose uptake in skeletal 
639 muscle [the primary site of postprandial glucose disposal (14)]. Akt activation 
640 (Thr308 and Ser473 phosphorylation) two hours after OGTT began, was 
641 unaffected by prior exercise or prior breakfast ingestion. However, the timing of 
642 muscle sampling could be responsible for this result. It is possible that 
643 differences in Akt activation between trials may have been apparent earlier in 
644 the postprandial period, as peak Akt phosphorylation can be variable, occurring 
645 as early as 30 min after an OGTT (35). Thus, despite the lack of a measurable 
646 difference, we cannot rule out a role for insulin signaling in the glucose disposal 
647 responses we observed. Distal proteins within the insulin signalling pathway can 
648 be activated after exercise, without detectable differences in Akt 
649 phosphorylation (61). We therefore measured AS160Thr642 activation as this  
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650 phosphorylation site has been previously shown to be activated by both insulin 
651 and exercise stimulation (58). However, our data show that AS160Thr642 
652 phosphorylation was not different two hours post-OGTT with breakfast versus 
653 fasting before exercise, providing further evidence that differences in early 
654 stages of the activation of the insulin signalling pathway were not responsible 
655 for the higher plasma glucose disposal rate we observed when breakfast was 
656 ingested before exercise. 
657  
658 AMPK activity also plays a key role in muscle glucose uptake and stimulate 
659 GLUT4 translocation (27). The greater post-exercise skeletal muscle AMPK 
660 activation with breakfast prior to exercise may have contributed to the higher 
661 glucose disposal rate in that trial. This AMPK response seems to be specific to 
662 skeletal muscle, as we have previously shown that post-exercise adipose tissue 
663 AMPK content is unaffected by pre-exercise feeding (12). The increase in 
664 skeletal muscle AMPK activity with pre-exercise feeding that we report in the 
665 present study may seem surprising given that the ingestion of large amounts (> 
666 200 g) of carbohydrate before and during exercise can blunt AMPK signaling in 
667 muscle (3, 29). This blunting is partly because low muscle glycogen 
668 concentrations stimulate AMPK activity (42). The modest amount (65 g) of 
669 carbohydrate ingested by participants in our study may explain why we did not 
670 observe an elevated AMPK response in our fasted-exercise trial. For example, 
671 when smaller carbohydrate doses are ingested before and/or during exercise (~ 
672 120 g or less) the exercise induced increase in the phosphorylation of AMPK 
673 and ACC is not always suppressed compared to when a placebo is ingested (2,  
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674 36, 58), although in one study this result was apparent despite a suppression of 
675 a2-AMPK activity when carbohydrate was ingested (2). 
676  
677 The heightened AMPK response observed in the current study with breakfast 
678 before exercise may be explained by the type of carbohydrate ingested before 
679 exercise (high-glycemic index) in the breakfast-exercise trial, as this can 
680 stimulate muscle glycogen use during exercise, especially when no 
681 carbohydrate is ingested during the activity (62). Thus, the high-glycemic index 
682 breakfast with a modest carbohydrate content in the present study, may have 
683 stimulated muscle glycogen utilization during exercise without supplying 
684 sufficient carbohydrate to replace additional glycogen utilization, resulting in 
685 lower post-exercise muscle glycogen concentrations with breakfast versus 
686 fasting before exercise. This could explain the enhanced exercise-induced 
687 AMPK response if breakfast was consumed prior to exercise. However, we had 
688 insufficient tissue to measure muscle glycogen concentrations in all participants, 
689 and our data only provide rates of muscle glycogen utilization (which was higher 
690 with feeding versus fasting before exercise). Nevertheless, in the two 
691 participants for whom we had sufficient tissue to perform glycogen analyses, 
692 these data were in agreement with the tracer-derived calculations of muscle 
693 glycogen utilization (data not shown) and AMPK signaling assessed by western 
694 blotting. Consistent with this, the present data demonstrated that post-exercise 
695 ACCSer79 phosphorylation - as a marker of activation of the AMPK pathway - 
696 positively correlated with muscle glycogen utilization during exercise. Thus, 
697 taken together our results suggest that the increased post-exercise plasma  
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698 glucose disposal rates with pre-exercise feeding versus fasting may have been 
699 mediated through enhanced AMPK signaling, which is itself a consequence of 
700 altered fuel use during exercise. AMPK signaling and resulting muscle glycogen 
701 concentrations following exercise after breakfast should now be explored. 
702  
703 The higher plasma glucose disposal rate (despite lower plasma insulin 
704 concentrations), that we observed in the breakfast-exercise trial, may be due to 
705 differences in GLUT4 trafficking downstream of the signalling proteins we 
706 measured. Insulin-stimulated GLUT4 translocation and insulin sensitivity of 
707 skeletal muscle are increased in vitro, if muscle is pre-treated with insulin, 
708 without differences in AktSer473 or AktThr308 activation, or the transport activity of 
709 GLUT4 (18). This suggests priming of skeletal muscle by prior insulin exposure 
710 enhances subsequent insulin action. Pre-treatment with insulin and exercise 
711 augments this response, possibly because insulin (33) and exercise (28) 
712 stimulate GLUT4 translocation from different intracellular stores (8, 49). As 
713 such, in the current work, prior breakfast and exercise (the multiple stimuli in 
714 BE), may have enhanced skeletal muscle GLUT4 translocation during the 
715 OGTT. Although technically challenging future work should now quantify GLUT4 
716 trafficking with fed versus fasted state exercise to confirm this. It is also possible 
717 that hepatic glucose disposal accounts for some of the increase in glucose 
718 disposal following BE versus FE. Similarly to skeletal muscle, insulin-stimulated 
719 hepatic glucose uptake is enhanced by prior exposure to insulin in dogs (44, 
720 45). Thus, assuming that this response persists in humans and after exercise,  
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721 priming of the liver by prior breakfast could also contribute to greater glucose 
722 disposal during meals consumed post-exercise. 
723  
724 The increases in post-exercise glucose disposal with prior breakfast 
725 consumption were, however, offset by alterations in plasma glucose 
726 appearance. As such, postprandial glucose concentrations did not differ 
727 between the two exercise trials. Postprandial plasma glucose appearance rates 
728 are determined by three main factors: 1) the appearance of glucose from the 
729 meal; 2) residual appearance of glucose from previous meals; and/or 3) liver 
730 glucose output (glycogenolysis or gluconeogenesis). We showed that 
731 alterations in the postprandial plasma glucose appearance rate (RaTOTAL) after 
732 exercise with prior breakfast was mostly driven by increased appearance of 
733 glucose from the post-exercise OGTT. These alterations in the RaT0TAL suggest 
734 that differences in gut function (i.e. increased intestinal damage or absorptive 
735 capacity) and/or splanchnic blood flow altered the RaT0TAL· Thus, breakfast prior 
736 to exercise may alter postprandial glycemia via factors related to intestinal 
737 absorption and splanchnic handling of glucose, rather than just glucose 
738 metabolism by skeletal muscle. 
739  
740 There are several potential mechanisms which may explain the differences in 
741 glucose appearance rates due to intestinal absorption and/or splanchnic 
742 handling of glucose. Plasma l-FABP concentrations are used as a marker of 
743 damage to intestinal epithelial cells (60). We noted lower plasma l-FABP 
744 concentrations in the breakfast-exercise versus fasted-exercise trial, despite  
Page 42 
 
 
745 increased plasma glucose appearance rates of the orally-ingested glucose 
746 post-exercise. It is therefore unlikely that increased intestinal damage was 
747 responsible for the higher plasma glucose appearance rates we observed with 
748 feeding versus fasting before exercise. The better maintenance of splanchnic 
749 perfusion during exercise with prior feeding is a likely explanation for this 
750 response (15). If splanchnic perfusion was better maintained during exercise 
751 with prior feeding, this may have also directly facilitated higher OGTT-derived 
752 glucose appearance rates in that trial versus the fasted-exercise trial. It should 
753 be acknowledged however, that this intestinal damage response may be 
754 specific to cycling, and could differ with other exercise modalities (e.g. running), 
755 within the context of pre-exercise feeding. An alternative mechanism for higher 
756 appearance rate of orally-ingested glucose with feeding before exercise could 
757 also be that apical glucose transporters were primed by the prior breakfast 
758 ingestion (40). Although further underlying mechanism(s) remain unclear, and 
759 should therefore be investigated with future work, we showed that a major 
760 determinant of post-exercise glycemia (plasma glucose appearance rates) are 
761 altered by pre-exercise feeding and that this is unlikely to be explained by 
762 increases in intestinal damage. 
763  
764 Our results show that the metabolic and intramuscular signaling responses to  
765 exercise conducted in a fed state cannot be readily inferred from responses  
766 observed with exercise in a fasted state. As well as a continual investigation of 
767 the mechanisms responsible for differences in postprandial glucose metabolism  
768 with altered pre-exercise feeding, future work should study whether the results  
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769 we observed are apparent with different post-exercise meals (including the co- 
770 ingestion of fat and protein). Moreover, if the acute alterations in postprandial 
771 metabolism translate into longer-term differences in insulin sensitivity with 
772 repeated bouts of exercise in the fed versus fasted state, and in overweight and 
773 obese populations, should now be a focus for future work. 
774  
775 To conclude, eating breakfast (versus fasting) before exercise increases post- 
776 exercise plasma glucose disposal rates but this is offset by increases in 
777 appearance rates of (mainly) orally-ingested glucose, a result that does not 
778 appear to be explained by a greater intestinal damage response to the exercise. 
779 We showed that pre-exercise breakfast consumption lowers insulinema at 
780 meals that are consumed post-exercise, providing new evidence that the 
781 second meal effect is maintained even when exercise is performed between 
782 eating occasions. 
783  
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TABLES 1014 
Table 1. Participant Characteristics 
Age (y) 23 (3) 
Stature (cm) 179.8 (4.4) 
Body mass (kg) 76.3 (7.9) 
Body Mass Index (kg·m-2) 23.6 (2.90) 
Fat mass (kg)1 10.6 (3.7) 
Fat Mass Index (kg·m-2)1 3.26 (1.12) 
Body fat (%)1 14 (4) 
Fat free mass (kg)1 65.5 (6.4) 
V̇O2peak (L·min
-1) * 4.00 (0.72) 
V̇O2peak (mL·kg·min
-1) * 53 (10) 
Peak Power Output (W) 317 (67) 
HRMAX, (beats·min
-1) 189 (10) 
Data are presented as means and (standard deviation). V̇O2peak = peak 
oxygen uptake. n = 12. *n = 11, due to technical difficulties with the breath-
by-breath analysis during one participant’s preliminary testing. 1 = derived 
by dual-energy x-ray absorptiometry (DEXA). 
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Table 2. Peak plasma concentrations, time to peak concentrations, and the time-averaged area 
under the curve (AUC) for various metabolites and hormones measured during the total within-lab 
period (300-min) and/or during an oral glucose tolerance test observation (120-min) that was 
conducted after breakfast followed by rest (Breakfast-Rest), breakfast followed by exercise 
(Breakfast-Exercise), or extended overnight fasting followed by exercise (Fasted-Exercise). 
Breakfast-
Rest 
Breakfast-
Exercise 
Fasted-
Exercise 
Peak glucose conc. (mmol·L
 1
) 10.62 (9.98, 11.25) 9.65 (9.27, 10.03) 
a
9.82 (9.44, 10.45) F = 4.895, p = 0.03 
Time to peak glucose (min) 36 (24, 47) 49 (36, 62) 49 (36, 61) F = 2.588, p = 0.12 
Glucose AUCTOTAL (mmol·L
-1
) 6.41 (6.21, 6.60) 6.05 (5.90, 6.15) 
a
6.07 (5.93, 6.27) F = 6.126, p = 0.01 
Peak insulin conc. (pmol·L
-1
) 286 (231, 341) 209 (148, 269) 282 (222, 337) F = 3.900, p = 0.07 
Time to peak insulin (min) 38 (26, 49) 56 (47, 65) 
a
43 (33, 54) F = 4.579, p = 0.03 
Insulin AUCTOTAL (pmol·L
-1
) 88 (79, 97) 62 (54, 71) 
aa
76 (67, 85) F = 9.28, p < 0.01 
NEFA AUCTOTAL(mmol·L
-1
) 0.16 (0.12, 0.19) 0.28 (0.24, 0.33)
aa
0.37 (0.31,0.42)
bb
F = 24.98, p < 0.01 
NEFA AUCOGTT (mmol·L
-1
) 0.10 (0.06, 0.14) 0.24 (0.20, 20.29) 
aa
0.26 (0.22, 0.31) 
bb
F = 15.51, p < 0.01 
Triglyceride AUCTOTAL (mmol·L
-1
) 0.85 (0.79, 0.91) 0.81 (0.75, 0.86) 0.75 (0.70, 0.79) F = 4.319, p = 0.03 
Triglyceride AUCOGTT (mmol·L
-1
) 0.84 (0.77, 0.92) 0.79 (0.72, 0.86) 0.70 (0.64, 0.77) F = 4.677, p = 0.02 
Lactate AUCTOTAL (mmol·L
-1
) 1.05 (0.96, 1.13) 1.19 (1.08, 1.30) 1.16 (1.07, 1.27) F = 3.645, p = 0.06 
Lactate AUCOGTT (mmol·L
-1
) 1.12 (1.04, 1.20) 0.97 (0.89, 1.04) 
aa
1.03 (0.96, 1.11) F = 6.479, p = 0.02 
β-hydroxybuturate AUCTOTAL 
(mmol·L
-1
)
0.03 (0.00, 0.06) 0.08 (0.06, 0.13) 
a
0.14 (0.09, 0.19) 
b
F = 5.936, p = 0.03 
I-FABP AUCTOTAL (pg·mL
-1
) 279 (242, 317) 304 (267, 366) 415 (353, 476) 
b
 
cc
F = 10.87, p < 0.01 
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Data are means and (normalized 95% confidence intervals). conc. = concentration; AUCTOTAL = the time-
averaged area underneath the concentration-time curve for the total within-lab period (300-min); AUCOGTT = the 
time-averaged area underneath the concentration-time curve for the oral glucose tolerance test (120-min); I-
FABP = intestinal fatty acid binding protein. n = 12 healthy men a represents a difference between breakfast 
rest and breakfast exercise, b a difference between breakfast rest and fasted exercise and c a difference 
between  breakfast exercise  and  fasted exercise with p < 0.05. aa, bb or cc is the same difference between 
trials but with p < 0.01. 
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LEGENDS TO FIGURES 1018 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted 1019 
after breakfast followed by rest (BR), breakfast followed by exercise (BE), or 1020 
extended overnight fasting followed by exercise (FE). Dual stable isotope 1021 
tracers ([U-13C] glucose ingestion and [6,6-2H2] glucose infusion) and muscle1022 
biopsies were combined to assess postprandial plasma glucose kinetics and 1023 
intramuscular signaling, respectively. 1024 
1025 
1026 
Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  1027 
(B), the total rate of plasma glucose appearance (RaTOTAL) (C), the rate of 1028 
appearance of glucose in plasma from the oral glucose tolerance test (RaOGTT) 1029 
(D), and the plasma enrichments of [2H2]-glucose (E) and [
13C]-glucose (F)1030 
before and during an oral glucose tolerance test that was conducted after 1031 
breakfast followed by rest (BREAKFAST-REST), breakfast followed by exercise 1032 
(BREAKFAST-EX), or extended overnight fasting followed by exercise 1033 
(FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 1034 
healthy men. a = difference between breakfast rest versus breakfast exercise; b 1035 
= breakfast rest versus fasted exercise and c = breakfast exercise versus fasted 1036 
exercise with p < 0.05. 1037 
1038 
Figure 3. Plasma glucose (A), plasma insulin (B), plasma non-esterified fatty 1039 
acids (NEFA; C), plasma β-hydroxybuturate (D) plasma triglyceride (E), and 1040 
plasma intestinal fatty acid binding protein (IFAB-P; F) concentrations before 1041 
and during an oral glucose tolerance test that was conducted after breakfast 1042 
followed by rest (BREAKFAST-REST), breakfast followed by exercise 1043 
(BREAKFAST-EX), or extended overnight fasting followed by exercise 1044 
(FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 1045 
healthy men. a = difference between breakfast rest versus breakfast exercise; b 1046 
= breakfast rest versus fasted exercise and c = breakfast exercise versus fasted 1047 
exercise with p < 0.05. 1048 
1049 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma insulin 1050 
(B) incremental area under the curves (iAUC) and the Matsuda insulin1051 
sensitivity index (C; ISIMATSUDA) for an oral glucose tolerance test conducted1052 
after breakfast followed by rest (BREAKFAST-REST), breakfast followed by1053 
exercise (BREAKFAST-EX), or extended overnight fasting followed by exercise1054 
(FASTED-EX). Data are means ± normalized 95% confidence intervals, with1055 
individual data shown as grey lines. n = 12 healthy men.1056 
1057 
Figure 5. The phosphorylation of 5' AMP-activated protein kinase (A; phospho 1058 
AMPKThr172, ratio p-AMPK to total-AMPK) and the phosphorylation of acetyl-1059 
CoA carboxylase (B; phospho ACCSer79, ratio p-ACC to total-ACC) before (PRE-1060 
OGTT) and after (POST-OGTT) an oral glucose tolerance test that was 1061 
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conducted after breakfast followed by rest (BREAKFAST-REST [BR]), breakfast 1062 
followed by exercise (BREAKFAST-EX [BE]), or extended overnight fasting 1063 
followed by exercise (FASTED-EX [FE]). All samples were taken from the 1064 
vastus lateralis. Samples were normalized to the baseline muscle sample for 1065 
each participant (collected in the resting fasted state on the first main trial for 1066 
each participant). Data are means ± normalized 95% confidence intervals. n = 9 1067 
healthy men. 1068 
1069 
Figure 6. The phosphorylation of Akt2 (A; phospho AktSer473, ratio p-Akt Ser473 to 1070 
total-Akt2 and B; phosphor AktThr308, ratio p-AktThr308 to total-Akt2) and the 1071 
phosphorylation of AS160 (C; AS160Thr642, ratio p-AS160Thr642 to total-AS160) 1072 
before (PRE-OGTT) and after (POST-OGTT) an oral glucose tolerance test that 1073 
was conducted after breakfast followed by rest (BREAKFAST-REST [BR]), 1074 
breakfast followed by exercise (BREAKFAST-EX [BE]), or extended overnight 1075 
fasting followed by exercise (FASTED-EX [FE]). All samples were taken from 1076 
the vastus lateralis. Samples were normalized to the baseline muscle sample 1077 
for each participant (collected in the resting fasted state on the first main trial for 1078 
each participant). Data are means ± normalized 95% confidence intervals. n = 9 1079 
healthy men. 1080 
1081 
Figure 7. Within-lab (300-min) substrate utilization after breakfast followed by 1082 
rest (BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), 1083 
or extended overnight fasting followed by exercise (FASTED-EX). Within-lab 1084 
substrate utilization was calculated assuming that the plasma glucose 1085 
disappearance rate was equivalent to plasma glucose utilization. Glycogen 1086 
utilization during exercise (on breakfast exercise and fasted exercise only) was 1087 
calculated as total carbohydrate utilization (from indirect calorimetry) minus 1088 
plasma glucose utilization during exercise. This estimate of muscle glycogen 1089 
utilization will therefore include the utilization of other non-glucose (e.g. lactate) 1090 
carbohydrates. GLU = glucose; M-GLY = muscle glycogen; PRO = protein; 1091 
CHO = carbohydrate. Data are presented as means ± 95% confidence 1092 
intervals. n = 12 healthy men.  1093 
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